Alphora Research

Alphora Research Inc. (now Eurofins CDMO Alphora Inc.) is a premier contract development and manufacturing organization (CDMO) based in Mississauga, Ontario, Canada. Founded in 2003, the company specializes in the development and manufacturing of complex and niche small molecule active pharmaceutical ingredients (APIs), with a particular expertise in highly potent and cytotoxic compounds. Following its acquisition by Eurofins Scientific in 2017, Alphora has significantly expanded its capabilities to include biologics development, such as monoclonal antibodies and protein-based therapeutics. The company operates multiple state-of-the-art facilities within the Sheridan Research Park, providing integrated services from preclinical development through to commercial manufacturing. Alphora is recognized for its advanced process chemistry, analytical development, and cGMP scale-up services, supporting a global clientele in the biopharmaceutical industry.